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This journal is ª The Royal Society ofNew dextrin nanomagnetogels as contrast agents for
magnetic resonance imaging
C. Gonçalves,a Y. Lalatonne,b L. Melro,a G. Badino,a M. F. M. Ferreira,c L. David,d
C. F. G. C. Geraldes,e L. Motte,b J. A. Martins†c and F. M. Gama*a
This study aims at the production and characterization of a “nanomagnetogel” consisting of
superparamagnetic iron oxide nanoparticles (g-Fe2O3) stabilized within a hydrophobized-dextrin
nanogel. The nanomagnetogel obtained was extensively characterized with respect to physico-chemical
(transmission electron microscopy, cryo-scanning electron microscopy, dynamic light scattering, small
angle X-ray scattering), magnetic (relaxometry, MIAplex) and biocompatibility (interaction with cells)
properties. The obtained nanomagnetogel formulation, with about 4 mM of iron and a diameter of
100 nm, presents relevant features as a promising magnetic resonance imaging (MRI) contrast agent,
noteworthy superparamagnetic behavior, high stability, narrow size distribution and potential for
magnetic guidance to target areas by means of an external magnetic field. High values of transverse
relaxivity make the nanomagnetogel a promising T2 contrast agent, allowing enhanced lesion
detectability through magnetic resonance imaging. The nanomagnetogel demonstrated non-toxicity for
3T3 fibroblast cultures and was efficiently internalized by bone marrow-derived macrophages, therefore
having potential as a contrast agent for MRI of the organs associated with the reticuloendothelial
system (spleen, liver). The production of the nanomagnetogel is simple and easy to scale up, thus
offering great technological potential.1. Introduction
Nanotechnology has tremendous potential to contribute
towards prevention, diagnosis, imaging, and treatment of
several diseases, based on the ability of not only carrying
multiple diagnostic/therapeutic payloads in the same package,
but also facilitating the targeted delivery into specic sites and
across complex biological barriers. In cancer imaging, magnetic
resonance imaging (MRI) can offer high spatial resolution and
the capacity to simultaneously obtain physiological and
anatomical information based on the interaction of contrast
agents with the surrounding protons of the tissues.1 Magnetic
nanoparticles (MNPs) exhibit a unique contrast enhancementeering, Centre for Biological Engineering,
-057, Braga, Portugal. E-mail: fmgama@
niversite´ Paris 13, Sorbonne Paris Cite´,
Campus de Gualtar, 4710-057 Braga,
yme`res (IMP@Lyon1) CNRS UMR 5223,
rd Lyon 1, 15 boulevard Latarjet, 69622
ade de Cieˆncia e Tecnologia, Centro de,
de Qu´ımica, Universidade de Coimbra,
Chemistry, University of Bath, UK.
Chemistry 2013that enables MRI of cell trafficking, gene expression, and cancer
detection.2–5 In addition, MNPs have been recognized as a
promising tool for site-specic delivery of drugs and of diag-
nostic agents through the application of an external magnetic
eld.4,6–11
Superparamagnetic iron oxide nanoparticles (SPION) are of
considerable interest as contrast agents due to their nanoscale
dimensions, nontoxic nature and magnetic properties. In
medicine, their application in the nude form is limited by their
agglomeration in biological uids, induced by their high
surface energies and hydrophobicity, which lead to protein
adsorption.12 Polymer coating provides colloidal stability in
water, through steric stabilization, giving well-dispersed
formulations. Surface coating of iron nanoparticles with
amphiphilic polymers has been described, essentially using
synthetic polymers and experimental methodologies relying on
organic solvents for phase transfer.13–15 Such strategies are still
limited for their extension to clinical applications, although
great efforts have been devoted to the development of simple
and effective methods to prepare nanocarriers with high
stability and narrow size distributions.
Size16 and surface properties17 of nanostructures are partic-
ularly important features which strongly affect both the blood
circulation time and the bioavailability of the particles within
the body. In addition, magnetic properties and internalization
depend on the size range.18 Particles ranging from circa 10 toJ. Mater. Chem. B, 2013, 1, 5853–5864 | 5853
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View Article Online100 nm are small enough to evade the reticuloendothelial
system (RES) as well as to penetrate very small capillaries within
the body tissues and, therefore, may offer the most effective
distribution in certain tissues.19 The RES, mainly the Kupffer
cells in the liver, usually takes up these particles due to their
hydrophobic surface and, therefore, results in efficient
opsonization.
Currently, two SPION are clinically approved, namely: fer-
umoxides (Feridex in the USA, Endorem in Europe) and fer-
ucarbotran (Resovist). The SPION effect is observed mainly on
T*2 relaxation and thus MRI is usually performed using T2/T
*
2-
weighted sequences in which the loss of tissue signal is due to
the susceptibility effects of the SPION oxide core. Regarding
the administration route, Resovist can be administered as a
rapid bolus (used with both dynamic and delayed imaging),
whereas Feridex needs to be administered by slow infusion
(used only in delayed phase imaging). In the liver, these
particles are sequestered by phagocytic Kupffer cells in normal
tissues, but are not retained in lesions lacking Kupffer cells.
Consequently, signicant differences in T2/T
*
2 relaxation
enhance lesion detectability. Both Feridex and Resovist are
approved specically for MRI of the liver, namely for detection
of hepatic metastases. Aer intravenous administration, clin-
ically approved SPION are cleared from the blood by phago-
cytosis accomplished in the RES, so that uptake is observed in
the normal liver, spleen, bone marrow, and lymph nodes. Aer
the intracellular uptake, SPIONs are metabolized in the lyso-
somes into a soluble nonsuperparamagnetic form of
iron, which becomes part of the iron pool (e.g., ferritin,
hemoglobin).20
In this study, we aim to develop a novel approach to prepare
uniform polymeric particles, by stabilizing iron oxide nano-
particles within dextrin nanogels – a class of nanocarriers well
suited for numerous specic delivery applications.21 Nanogels
can be formulated by the self-assembly of amphiphilic poly-
mers. In such a typical self-assembled formulation, the hydro-
phobic nanodomains formed within a nanogel can be loaded
with a variety of therapeutic molecules or imaging agents.22
Dextrin is an affordable biomaterial, available in large amounts,
highly biocompatible, biodegradable and readily excreted
through the kidneys due to its fairly low molecular weight.
Although already used in the biomedical industry, and available
in medical grade, it is clearly underexploited. We aim to develop
an effective “nanocarrier” for iron oxide nanoparticles that
ensures colloidal stability at physiological pH. The targeted
applications are RES organs – as in the case of the aforemen-
tioned commercial formulations – or tumor sites, taking
advantage of either the enhanced permeation and retention
(EPR) effect or active targeting. Therefore, a nanomagnetogel for
use as a contrast agent for MRI should exhibit the following
properties: (i) high relaxivity, therefore better contrast, mini-
mizing dosage; (ii) size bellow 100 nm, and narrow size distri-
bution, for bolus intravenous administration, instead of slow
intravenous infusion; (iii) appropriate coating to allow the
magnetic particles to be stable under physiological conditions;
(iv) importantly, the coating should be nontoxic and easily
cleared from the body.5854 | J. Mater. Chem. B, 2013, 1, 5853–58642. Experimental section
2.1. Materials
Dextrin-VA (dexVA) and dextrin-VA-SC16 (dexC16) were synthe-
sized as comprehensively described before.23 DexVA consists of
a dextrin backbone with graed acrylate ester groups (VA—vinyl
group). DexC16 is composed of the hydrophilic dextrin back-
bone with graed VA groups, which are partially substituted
with long alkyl chains (SC16). In this work, dexC16 with 30 vinyl
groups (DSVA 30%) and 4.5 or 14.0 hexadecanethiol chains
(DSSC16 4.5 or 14.0%) per 100 dextrin glucopyranoside residues
were used. For the sake of simplicity, nanogels containing 4.5 or
14.0% of alkyl chains will be named nanogel 1 (NG1) or nanogel
2 (NG2), respectively.2.2. Preparation of polymer-coated g-Fe2O3 nanoparticles
The nanogel was obtained by dispersion of dexC16 (lyophilized
powder) in distilled water, under stirring at 50 C, until a clear
solution was obtained. The dispersion was then ltrated
through a 0.22 mm syringe lter. The polymer concentration
must be higher than 0.008mgmL1, previously identied as the
critical micelle concentration (cmc),23 required for the amphi-
philic polymer to self-assemble in water, producing nano-
structures internally stabilized through the hydrophobic
domains24 and allowing the solubilization of hydrophobic
molecules.25
Water-soluble bare g-Fe2O3 nanoparticles were prepared via
our previously published approach.26 In a typical synthesis
procedure, the rst step is to add dimethylamine
((CH3)2NH2OH) to an aqueous micellar solution of ferrous
dodecyl sulphate (Fe(DS)2). The nal concentrations aer mix-
ing of the reactants are 1.3  102 mol L1 and 8.5  101 mol
L1 for Fe(DS)2 and dimethylamine, respectively. The solution is
stirred vigorously for 2 h at 28.5 C and the resulting precipitate
of uncoated nanocrystals is isolated from the supernatant by
applying a magnetic eld. In the second step, this precipitate is
washed with a large excess of DI water and redispersed at pH 2.0
leading to stable cationic nanoparticles (zeta ¼ +38 mV and
isoelectric point ¼ 7.8).27
g-Fe2O3 nanoparticles were loaded into the hydrophobic
nanodomains of a dextrin nanogel dispersed in distilled water
through hydrophobic–hydrophobic interactions.28 The physical
entrapment of g-Fe2O3 into the nanogel was performed
following the nanogel preparation procedure, as described
above. A stock solution of g-Fe2O3 (270 mM Fe) was used. The
required volume of stock solution was added to the nanogel
dispersion and the pH was adjusted to 7.4. The formulation was
kept under circular stirring overnight to allow g-Fe2O3 incor-
poration into the nanogel, through hydrophobic/hydrophobic
interactions. Aer that, formulations were centrifuged at 4000g
for 10 min (room temperature), to remove non-stabilized
g-Fe2O3. The supernatant was carefully collected and analyzed.
The effect of the nanogel/g-Fe2O3 ratio on the loading effi-
ciency and stability of the formulation was studied. Different
nanogel@g-Fe2O3 formulations were prepared, using distilled
water as the dispersion medium, by varying the ironThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlineconcentration (1.4, 5.0, 10.0 mM) and the polymer concentra-
tion (1.0 or 2.0 mgmL1). In order to evaluate the stability of the
dispersions, they were maintained at 4 C up to 8 weeks as
described below.2.3. Physico-chemical characterization of polymer-coated
g-Fe2O3 nanoparticles (nanogel@g-Fe2O3)
2.3.1. g-Fe2O3 loading. The iron quantication was carried
out by atomic absorption spectroscopy (AAS) (GBC 932 Plus,
PerkinElmer). The instrument response was periodically
checked using appropriate standard solutions. Formulations
were stored at 4 C until measurement.
2.3.2. Size distribution and colloidal stability. The formu-
lation stability was evaluated by analysing the nanogel size
distribution, up to 8 weeks, keeping the formulation at 4 C. The
size distribution was determined by dynamic light scattering
(DLS) using a Malvern Zetasizer, model Nano ZS (Malvern
Instruments Limited, UK). The nanogel dispersion was ana-
lysed at 25 C in a polystyrene cell, using a He–Ne laser – a
wavelength of 633 nm and a detector angle of 173. The DLS
analysis provides the characterization of a sample through the
mean value (z-average) for the diameter, and a width parameter
known as the polydispersity index (PdI).
2.3.3. Microscopy: cryo-SEM and TEM. For Cryo-SEM
analysis, nanogel@g-Fe2O3 formulations were rapidly
immersed in liquid nitrogen slush at 95 C for 2 min and
vacuum transferred to an Alto 2500 (Gatan Inc., CA) cryo prep-
aration chamber attached to a JEOL JSM 6301F scanning elec-
tron microscope. Frozen samples were fractured at 95 C,
etched for 10 seconds (to partially sublime water from the
fractured nanogel surface), and nally gold-coated for 2 min.
Samples were viewed at 50 C and the resulting SEM images
were analyzed using ImageJ soware (National Institute of
Health, USA).
Transmission electron microscopy (TEM) micrographs were
obtained using a JEOL 2010 TEM instrument at an accelerating
voltage of 160 kV. Samples were prepared by wetting carbon-
coated grids with a small drop of colloidal dispersions.
2.3.4. SAXS experiment. The SAXS experiment was carried
out at the European Synchrotron Radiation Facility (Grenoble,
France) on the BM2-D2AM beamline. The suspensions were
installed in silica tubes (external diameter of 3 mm, wall
thickness of 0.2 mm, 76 mm long, from Deutero GmbH, ref.
2000942) with elastomer closure caps to avoid water evapora-
tion (Deutero ref. 29 604 15). The incident photon energy was
set to 16.000 keV to limit attenuation by the glass tubes. We
used a 2D CCD X-ray detector from Roper Scientic. The images
were corrected for camera distortion, dark image reading and
the at eld response of the detector. Finally, the image center
(“gravity center” of the incident beam) was determined with
attenuators and radial averages yielded 1D proles (processing
carried on the beamline, with bm2img soware). The angle or
q-calibration was performed thanks to a silver behenate powder
standard placed in a glass tube in the 21-sample holder. The
subtraction of the scattering contribution of the empty cell
(glass tube lled with water) was performed by measuring theThis journal is ª The Royal Society of Chemistry 2013attenuation coefficient of the samples. A dextrin nanogel (NG1
or NG2) was dispersed in distilled water.
2.3.5. Magnetic properties
2.3.5.1. Relaxometry. Magnetic resonance relaxometry was
used to measure the longitudinal (T1) and transverse (T2) proton
relaxation times for the nanogel@g-Fe2O3 formulations.
Measurements were performed using a Bruker Minispec mq20
relaxometer operating at a magnetic eld of 0.47 T, corre-
sponding to a Larmor frequency of 20 MHz, and at a tempera-
ture of 25 C. T1 and T2 relaxation times were obtained using the
inversion-recovery (IR) and Carr–Purcell–Meiboom–Gill (CPMG)
pulse sequences, respectively. The reproducibility of the relax-
ation time determinations was found to be better than 1%.
The corresponding relaxivity values, r1 and r2, were calculated
through the least-squares curve tting of 1/relaxation time Ri
(i ¼ 1,2) (s1) versus the iron concentration (mM Fe).
2.3.5.2. MIAplex assay. In the MIAplex (Multiplex
Magnetic Immuno Assays) instrument, a magnetic material is
exposed simultaneously to two alternative magnetic elds, a
magnetic eld of low frequency f1 ¼ 0.025 Hz and a magnetic
eld of higher frequency f2 ¼ 24.4 kHz. During MIAplex
measurements, the amplitude of the high frequency magnetic
eld (f2) is xed at a value lying between 8.88 Oe and 8.88 Oe,
while the amplitude of the low frequency magnetic eld (f1) is
varied between 452.4 Oe and 452.4 Oe. A signal, which is
proportional to the second derivative of the magnetization
curve of the material, d2M/dH2, is then recorded, at room
temperature, when the amplitude of the high frequency
magnetic eld is varied.292.4. In vitro studies
2.4.1. Nanomagnetogel guidance and stability under an
external magnetic eld. Magnetic nanoparticles loaded into a
nanogel offer the possibility of magnetically guiding the
formulations. To understand the nanomagnetogel responsive-
ness/stability under a magnetic eld, an in vitro study was
performed. Nanogel@g-Fe2O3 formulation, using NG1
(2.0 mg mL1) and 5.0 mM of initial iron concentration was
prepared, as previously described. An Eppendorf tube contain-
ing the nanomagnetogel dispersion was placed next to a magnet
overnight, allowing the accumulation of the nanomagnetogel
particles next to the magnet. Then, the supernatant was
collected without removing the magnet and the total volume
was replaced with freshly distilled water; nally, the magnet was
removed and the accumulated pellet was redispersed. The
samples “before magnet”, “aer magnet” and “redispersed”
were analyzed by atomic absorption spectroscopy for iron
quantication. Each sample was also analyzed by Fourier
transform infrared spectroscopy (FTIR), aer lyophilisation, to
ascertain whether the nanogel co-localizes with iron oxide,
during magnetic eld application.
For FTIR analysis, KBr tablets of each sample were prepared
by mixing 2.5 mg of the sample with KBr (total mixture mass of
250 mg). Themixture was ground until a homogeneous and ne
powder was obtained. The material was pressed using a
hydraulic press, for ca. 3 min, to form the tablet. The tablet wasJ. Mater. Chem. B, 2013, 1, 5853–5864 | 5855
Scheme 1 Schematic of a nanomagnetogel for use as an MRI contrast agent
and drug delivery system.
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View Article Onlinegently taken out of the mold and kept at 60 C overnight, before
analysis, to make sure that samples were properly dried. The
tablet should be translucent; otherwise, the spectrum may have
low-resolution, since little infrared radiation passes through the
sample. A background reading was performed before sample
analysis in a FTIR spectrophotometer (Nicolet 380 FTIR Thermo
Electro Corporation).
2.4.2. Cell cultures
2.4.2.1. Mouse embryo broblasts 3T3 culture.Mouse embryo
broblasts 3T3 (ATCC CCL-164) were grown in Dulbecco's
modied Eagle's medium supplemented with 10% newborn
calf serum (Invitrogen, CA) and 1% penicillin/streptavidin
(DMEM complete medium [cDMEM]) at 37 C in 95% humidi-
ed air containing 5% CO2.
2.4.2.2. Murine bone marrow-derived macrophages (BMDM).
Macrophages were obtained from mouse bone marrow as
follows: mice were sacriced and femurs and tibias removed
under aseptic conditions. Bones were ushed with Hank's
balanced salt solution. The resulting cell suspension was
centrifuged at 500  g for 10 min and resuspended in RPMI
1640 medium supplemented with 10 mM HEPES, 10% heat-
inactivated fetal bovine serum (FBS), 60 mg mL1 penicillin/
streptavidin, 0.005 mM b-mercaptoethanol (complete RPMI
[cRPMI]), and 10% L929 cell conditioned medium. To remove
broblasts or differentiated macrophages, cells were cultured
on cell culture dishes (Sarstedt, Canada), overnight at 37 C in a
5% CO2 atmosphere. Then, non-adherent cells were collected
with warm cRPMI and centrifuged at 500  g for 10 min. Cells
were distributed on 24-well plates (Sarstedt, Canada) at a
density of 5 105 cells per well (1 mL) and incubated at 37 C in
a 5% CO2 atmosphere. Four days aer seeding, 10% of L929 cell
conditioned medium was added, and the medium was renewed
on the seventh day. Aer ten days in culture, cells were
completely differentiated into macrophages. This method
allows for the differentiation of a homogeneous primary culture
of macrophages that retain the morphological, physiological
and surface marker characteristics of these phagocytic cells.30,31
2.4.3. Cell interaction studies
2.4.3.1. Cell viability – MTT assay. The viability of mouse
embryo broblast 3T3 cells, aer incubation with nanogel or
nanogel@g-Fe2O3 formulations, was evaluated, in vitro, using
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay. The tetrazolium salt is widely used to
quantify cell viability, by colorimetry. In this test, the tetrazo-
lium salt is metabolically reduced to highly colored end prod-
ucts, formazans.32 The succinate-tetrazolium reductase system,
which belongs to the mitochondrial respiratory chain, is active
only in viable cells. The measured absorbance (at 570 nm) is
proportional to the global metabolic activity that is hypothe-
sized to be proportional to the number of viable cells. For each
sample, the background optical density (evaluated at a wave-
length of 690 nm) was subtracted; the test was performed in
triplicate for each condition.
A negative control experiment was performed using cells
without any treatment (growing in culture medium). Nanogel or
nanogel@g-Fe2O3 formulations, using NG1 or NG2, were incu-
bated with cells, for 24 or 48 h. The MTT assay was performed at5856 | J. Mater. Chem. B, 2013, 1, 5853–5864the beginning (0 h) to check the absorbance of cell cultures, in
order to investigate the cell growth during the assay. Each
formulation was diluted in the culture medium using different
dilution factors (DF), DF5 and DF10. These values are based on
the assumption that, when using a mouse model, the injection
of 200 mL on the blood circulation (whose total volume is
around 1500 mL) would result in a dilution factor of 7.5. The
nanogel concentrations tested are 0.4 mg mL1 and 0.2 mg
mL1 in the DF5 and DF10 conditions, respectively.
MTT was added, at each time point, to the culture medium
with a nal concentration of 0.5 mg mL1. Aer 3 h of incu-
bation, the insoluble formazan crystals were solubilized with
DMSO, and the absorbance was measured at 570 and 690 nm
using an automated ELISA plate reader.
2.4.3.2. Phagocytic activity – Prussian blue. In order to eval-
uate the phagocytic activity, murine bone marrow derived
macrophages (5.0  105 cells per well) were seeded on cover-
slips and exposed to the nanogel (NG1) 0.4 mg mL1, as the
negative control, or NG1@g-Fe2O3 formulation (nanogel
0.4 mg mL1; iron 0.8 mM) for 3 h. The cover glasses were
washed twice with PBS aiming to remove the excess iron. Aer
that, the iron content of the cells was assessed using the Prus-
sian blue staining procedure (5% potassium ferrocyanide and
5% HCl mixed 1 : 1 for 30 min). Cover glasses were analysed
using an inverted light microscope (Leica DM IL).
3. Results and discussion
3.1. Characterization of polymer-coated g-Fe2O3
nanoparticles (nanogel@g-Fe2O3)
3.1.1. g-Fe2O3 loading. The coating of SPION with amphi-
philic polymers is a suitable strategy to achieve colloidal
stability of iron oxide in water through steric stabilization. Self-
assembled hydrogel nanoparticles (nanogel) from amphiphilic
polymers provide an interesting architecture wherein the
hydrophobic nanodomains serve as suitable carriers for
hydrophobic iron oxide nanoparticles; the hydrophilic
polymeric matrix allows for particle stabilization in aqueous
solution (Scheme 1).
The stabilization of g-Fe2O3 nanoparticles within a dextrin
nanogel was studied, using different iron concentrations (1.4,
5.0 or 10.0 mM) added to a nanogel concentration of 1.0 or
2.0 mg mL1. Each formulation was prepared using NG1This journal is ª The Royal Society of Chemistry 2013
Fig. 1 Iron concentration (mM) effectively stabilized (incorporated within the
nanogel) after the addition of different iron concentrations (1.4, 5.0 or 10.0 mM)
within 1.0 or 2.0 mg mL1 of NG1 ( ) or NG2 ( ), as determined by atomic
absorption spectroscopy. Results represent the mean  S.D. of at least 2 inde-
pendent assays.
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View Article Online(DSSC16 4.5%) and NG2 (DSSC16 14.0%), so as to understand the
impact of the dextrin degree of substitution on the loading
capacity. Aer the mixture, pH was adjusted to 7.4 and formu-
lations were incubated overnight, at room temperature. Aer
incubation, non-stabilized g-Fe2O3 was removed through
centrifugation (4000g, 10 min). The concentration of stabilizedFig. 2 Size distribution in intensity (a) and zeta potential of nanogel@g-Fe2O3 (NG
Fe2O3 nanoparticles, 4.0 mM Fe at pH 2.0 (c).
This journal is ª The Royal Society of Chemistry 2013g-Fe2O3 (supernatant) was determined by atomic absorption
spectroscopy (Fig. 1).
Concerning the inuence of the dextrin degree of substitu-
tion with hydrophobic chains, only a minor difference in the
loading capacity was observed comparing NG1 (DSSC16 4.5%)
and NG2 (DSSC16 14.0%). Therefore, we only used NG1 since it
contains less hydrophobic chains and no signicant benet
results from using a higher DSC16.
An increase in nanogel concentration (from 1.0 to
2.0 mg mL1) does not result in signicantly higher loadings,
when lower initial iron concentrations were used. When a
higher initial iron concentration was used (10 mM), a slight
increase in iron incorporation was observed for the higher
nanogel concentration. Since even higher nanogel concentra-
tions are not possible, since 2.0 mg mL1 is already close to the
solubility limit, a nanomagnetogel with NG1 2.0 mg mL1 and
10.0 mM of initial iron concentration was selected as the most
promising one, which corresponds to a formulation with about
4.0 mM of iron.
3.1.2. Size distribution, zeta potential and colloidal
stability. Modied dextrin self-assembles in water, producing a
nanogel with a bimodal size distribution with two populations1 2.0 mg mL1 loaded with 4.0 mM Fe) at pH 7.4 (b) and zeta potential of bare g-
J. Mater. Chem. B, 2013, 1, 5853–5864 | 5857
Fig. 3 Size evaluation (diameter, nm) of different nanogel@g-Fe2O3 formula-
tions (pH 7.4) using NG1 2.0 mg mL1 loaded with 0.7 (,), 2.2 (D) or 4.0 () mM
of iron, up to 8 weeks. Results represent the mean  S.D. of 5 consecutive
measurements.
Fig. 4 Cryo-SEM images of nanogel@g-Fe2O3 formulations: (a) NG1
2.0 mg mL1, iron concentration of 2.2 mM, 10 000; and (b) NG1 1.0 mg mL1,
iron concentration of 2.2 mM, 50 000.
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View Article Onlinewith diameters 20 and 100 nm, as shown previously.33
Remarkably, aer g-Fe2O3 addition, the size distribution prole
exhibits a single peak and an average diameter around 100 nm
(Fig. 2a).
The nanomagnetogel shows a zeta potential value close to
zero (7.77 mV) (Fig. 2b), as previously reported for the dextrin
nanoparticles without iron (5.0 mV).24 Bare g-Fe2O3 nano-
particles present a large positive zeta potential value, 41.7 mV
(Fig. 2c). The zeta potential value demonstrates that the iron
oxide particles are internalized within the nanogel, such that
the nanomagnetogel has a near neutral surface charge. SimilarFig. 5 TEM images of bare g-Fe2O3 nanoparticles (a) and nanogel@g-Fe2O3 formu
NG2 iron concentration of 2.2 mM (scale bar 200 nm).
5858 | J. Mater. Chem. B, 2013, 1, 5853–5864results were obtained for the encapsulation of magnetic nano-
particles into liposomes.34
The stability of different nanogel@g-Fe2O3 formulations in
water was evaluated by analysing the size distribution (intensity-
weighted diameter), up to 8 weeks. As can be seen in Fig. 3, the
size distribution is almost the same for all formulations studied
(80–120 nm) and the hydrodynamic size (diameter) is constant
up to 8 weeks of storage (4 C).
The results suggest that the formulations obtained may have
satisfactory shelf stability, although longer assays (up to one
year) must still be carried out.
3.1.3. Microscopy: cryo-SEM and TEM. In order to visualize
the size distribution and the shape of the nanomagnetogel,
nanogel@g-Fe2O3 formulations were visualized by cryo-SEM
and TEM.
As can be seen in Fig. 4, the nanomagnetogel has a spherical
shape and the size distribution is in good agreement with the
previously presented DLS results. Scanning electronmicroscopy
is not suited to reveal the presence of core iron nanoparticles.
For this purpose, formulations were also visualized by trans-
mission electron microscopy. This technique allows the visu-
alization of iron oxide nanoparticles as dark spots. TEM images
present a clear difference in nanoparticle organization
depending on the presence or absence of the nanogel (Fig. 5). A
uniform deposition on the TEM grid is observed for bare
g-Fe2O3 nanoparticles prepared under acidic conditions
(Fig. 5a).
Fig. 5b and c show g-Fe2O3 clusters that must be stabilized
by the nanogel; otherwise, the iron oxide would precipitate at
pH 7.4. Indeed, the as-synthesized nanoparticles present an
isoelectric point (IEP) of 7.8.27 The TEM images demonstrate
that the nanomagnetogel comprises magnetic iron oxide
nanoparticles randomly distributed within the polymer struc-
ture. Due to a low polymer contrast, the dextrin corona cannot
be seen in the TEM images. The nanomagnetogel size is not
affected by the degree of substitution of the polymer, since
similar results were obtained for NG1 (Fig. 5b) and NG2
(Fig. 5c).
3.1.4. SAXS analysis of dextrin nanogel. The internal
nanostructure of iron-free nanogels (NG1 and NG2) was studied
by small angle X-ray scattering (SAXS), in a convergent approach
with the electron microscopy study of the nanomagnetogellations using 2.0 mg mL1 nanogel: (b) NG1 iron concentration of 2.0 mM and (c)
This journal is ª The Royal Society of Chemistry 2013
Fig. 6 SAXS analysis of NG1 and NG2 at 5.0 and 10.0 mg mL1.
Fig. 7 MIAplex signal of the nanogel@g-Fe2O3 formulation Fe ¼ 1.4 mM
(dotted line) compared to bare g-Fe2O3 nanoparticles (full line).
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View Article Onlinepresented above. The SAXS analysis reveals the nanoscaled
organization of hydrophobic domains within the nanogel
structure. The scattering patterns shown in Fig. 6 for NG1 and
NG2 at two different concentrations are typical of micellar
organizations with the gyration radius between 6.3 and 7.1 nm
(diameter about 13–15 nm) and a form factor maximum in the
q-range from 0.1 to 0.15 A˚. The scattering pattern is thus due to
the micellar organization within the nanogels and yields the
gyration radius of the micelles. The number of hydrophobic
domains within the nanogel was previously reported and
depends on the degree of substitution of the polymer used: it
varies from 15 to 22 for DSC16 4.5 and 10.0%, respectively.24 The
hydrophobic nanodomain sizes obtained here are compatible
with such estimations. As shown in Fig. 6, the intraparticular
sizes of nanodomains within the nanogels are weakly affected
by the degree of substitution of the polymer, since similar
results were obtained for NG1 and NG2.
Iron oxide nanoparticles, mostly in the 10–20 nm size range,
were visualized by electron microscopy (Fig. 5) and organized in
small clusters in the presence of nanogels. Such nanoparticles
are known to be stabilized in the hydrophobic core of polymer
micelles.15 Therefore, we can assume that themain driving force
for the internalization of iron nanoparticles within the nanogels
is due to the hydrophobic interactions between iron oxide
nanoparticles and the hydrophobic domains since they exhibit
sizes (above 10 nm diameter) compatible with the internaliza-
tion of an individual iron oxide nanoparticle. Thus, the hydro-
phobic domains may play a key role in the internalization of
iron oxide particles. Further studies are necessary to conclude if
the hydrophobic domain structure is affected by the presence of
g-Fe2O3 particles, and which hydrophobic domain nano-
structure is the most suited for iron oxide nanoparticle inter-
nalization (number of hydrophobic nanodomains per nanogel,
aggregation number in hydrophobic nanodomains, etc.).24
3.1.5. Magnetic properties. Numerous experimental and
clinical studies have shown that the use of high relaxivity
contrast agents results in improved detection and delineation of
tumors allowing a more reliable diagnostic.1 SPIONs have beenThis journal is ª The Royal Society of Chemistry 2013clinically used as T2-type (negative) MRI contrast agents.35,36
Superparamagnetic behavior means that the nanoparticles are
highly magnetized in a magnetic eld but lose their magneti-
zation when the eld is switched off. This behavior is important
for injectable formulations, because it reduces the risk of
thrombosis from magnetically aggregated nanoparticles.
Increasing SPION size can increase its transverse relaxivity.37
However, the large particles (with sizes approximately larger
than 15 nm) are not superparamagnetic and easily aggregate in
solution.28 A strategy to increase T2 relaxivity, while keeping the
superparamagnetic characteristics, is clustering individual
SPIONs into clusters, within a polymeric structure such as, in
this work, dextrin, which determines their physical parameters,
such as the apparent hydrodynamic diameter and surface
charge.
The as-synthesized nanocrystals exhibit superparamagnetic
behavior at room temperature and do not present remanence as
well on magnetization as a second derivative of the magneti-
zation curve. The magnetic properties of nanomagnetogel
formulations were investigated with a MIAplex magnetometer
at room temperature. The second derivative of the magnetiza-
tion curves obtained for the nanomagnetogel is not modied
compared to bare nanoparticles (Fig. 7). No hysteresis loops
appear and this result indicates that the nanogel formulation
preserves its superparamagnetic behavior.38
The performance of different nanogel@g-Fe2O3 formula-
tions as potential MRI contrast agents was evaluated based on
relaxometric measurements. The relaxation times (Ti), the water
proton relaxation rate enhancements (Ri ¼ 1/Ti) per mM Fe
concentration and relaxivities (ri) (i ¼ 1 for longitudinal or i ¼ 2
for transverse) are good in vitro indicators of their efficiency as
positive or negative MRI contrast agents. The inverse relaxation
times, Ri, vary linearly with the Fe concentration, according to
eqn (1)
R1,2 ¼ r1,2 [Fe] + R1,20 (1)
where R1,2
0 are the inverse relaxation times in pure water.
As presented above, nanogel@g-Fe2O3 formulations were
prepared, and depending on the nanogel concentration and on
the amount of iron added, different amounts of iron can be
stabilized within hydrophobic nanodomains. r1 and r2 valuesJ. Mater. Chem. B, 2013, 1, 5853–5864 | 5859
Fig. 8 Longitudinal (,) and transverse (B) relaxivities of nanogel@g-Fe2O3 formulations using 2.0 mgmL
1 NG1 loaded with (a) 4.0, (b) 2.2 and (c) 0.7 mM of iron or
2.0 mg mL1 NG2 loaded with (d) 4.3 and (e) 2.2 mM of iron, plotted against iron concentration (dilution assay).
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View Article Onlinewere obtained, aer the graphic representation of eqn (1), for
different nanogel@g-Fe2O3 formulations using NG1 or NG2
(Fig. 8). Therefore, each formulation was diluted and the
relaxation time was measured at ve different iron concentra-
tions. r1 and r2 values obtained for each formulation are pre-
sented in Table 1. As can be seen, r1 values vary from 11.3
up to 30.6 mM1 s1 and r2 from 176.3 mM
1 s1 up to
278.4 mM1 s1. Similar transverse relaxivities were obtained
using NG1 or NG2. Regarding longitudinal relaxivities, NG1
displays a slight increase when compared to NG2. For both
nanogels, an increase in iron content results in higher values of
relaxivity. An effect that can be explained by increased dipolar
interactions which result from the increase of g-Fe2O3 nano-
particles into the nanogel and leading to higher r2 values.39
Previous studies indicate that clustering magnetic nano-
particles result in enhanced transverse relaxivity. Berret et al.
fabricated a maghemite nanocluster and tuned the size of
aggregates in the 70–150 nm range with aggregation numbers
(number of nanoparticles per aggregate) from tens to hundreds.
It was found that r2 was noticeably increased with the size of the
magnetic clusters.40 Ai et al. had also obtained a similar result
for magnetic nanoparticles encapsulated into the hydrophobic
cores of 20–100 nm polymeric micelles.415860 | J. Mater. Chem. B, 2013, 1, 5853–5864Ferumoxides and ferucarbotran are commercial SPIONs
coated with low molecular weight dextran and carboxydextran,
respectively. Regarding the particle size, Feridex is 72 nm42 and
Resovist is 65 nm43 in diameters. Table 1 shows longitudinal (r1)
and transverse (r2) relaxivities of NG1 or NG2 formulations,
prepared in this work, in comparison with the values of
commercial products.
Nanogel@g-Fe2O3 formulations are promising as T2 contrast
agents due to the larger r2 value. It appears that formulations
developed in this study exhibit superior relaxivity properties
than those commercially available. Nanomagnetogels loaded
with the highest iron content (around 4.0 mM) present high
potential as contrast agents for MRI, as shown in Table 1.3.2. In vitro studies
3.2.1. Nanomagnetogel accumulation by an external
magnetic eld. The entrapment of magnetic nanoparticles
inside a nanogel leads to the formation of a nanomagnetogel
which may be magnetically driven under an external magnetic
eld. We have observed this response by placing (overnight) a
magnet next to an Eppendorf tube containing the nano-
magnetogel dispersion.This journal is ª The Royal Society of Chemistry 2013
Table 1 Values of longitudinal (r1) and transverse (r2) relaxivities of NG1 or NG2
(2.0 mg mL1) formulations compared with commercial products obtained from
the literature (values at 0.47 T, 20 MHz)
Material r1 (mM
1 s1) r2 (mM
1 s1)
Ferumoxides
(Feridex, AMI-25, Endorem)42
40 160
Ferucarbotran (Resovist)43 25 177
NG1Fe 4.0 mM 31  0.3 278  2.3
NG1Fe 2.2 mM 25  0.1 238  0.3
NG1Fe 0.7 mM 11  0.04 176  0.9
NG2Fe 4.3 mM 24  0.2 257  4.5
NG2Fe 2.2 mM 20  0.1 240  0.7
Fig. 9 Demonstration of nanomagnetogel accumulation under an external
magnetic field (overnight).
Fig. 10 FTIR spectra of (a) nanogel, (b) bare g-Fe2O3, (c) nanomagnetogel
before magnet application, (d) sample after magnet application and (e) redis-
persed material resulting from magnet application.
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View Article OnlineAs shown in Fig. 9, the nanomagnetogel was attracted by the
magnetic eld and concentrated on the Eppendorf wall, next to
the magnet. We aimed at understanding whether the magnetic
eld application induces nanomagnetogel accumulation or
only iron NP accumulation, due to putative disassembly of the
nanomagnetogel. Three samples were taken for qualitative
(FTIR) and quantitative (atomic absorption spectroscopy) eval-
uation: before magnetic eld application, supernatant aer
magnetic eld application (without removing the magnet) and
redispersed material in fresh water (aer magnet remotion).
Atomic absorption spectroscopy reveals that the initial
colloidal nanomagnetogel suspension has 2.2 mM of iron
(“before magnet”), which is halved to 1.1 mM of iron, aer the
application of the magnetic eld (“aer magnet”); aer magnet
removal, the material dispersion leads to 0.8 mM of iron in the
“redispersed” sample.
Fig. 10a shows the nanogel FTIR spectra, where the carbonyl
group band appears at 1723 cm1 and other dextrin bands
appear at 1635, 1408, 1296, 1192 and 1023 cm1.44 Otherwise,This journal is ª The Royal Society of Chemistry 2013g-Fe2O3 (Fig. 10b) reveals a single peak in the FTIR spectrum at
580 cm1.45 Before magnet application, the FTIR spectrum of
the nanomagnetogel contains peaks assigned to the nanogel
and g-Fe2O3 (Fig. 10c). FTIR results demonstrate that, aer
magnetic eld application, part of the nanomagnetogel remains
dispersed in the supernatant fraction (Fig. 10d). In order to
increase the nanomagnetogel accumulation, longer periods of
time or a stronger magnet should be applied. On the other
hand, the fraction retained due to magnetic eld application
contains both iron and the nanogel, as can be veried from
Fig. 10e (“redispersed material”). This experiment demon-
strates the possibility of magnetically guiding the nano-
magnetogel to the targeted area through application of an
external magnetic eld, without compromising the nano-
magnetogel integrity.
3.2.2. Cell viability – MTT assay. In the cell interaction
studies, nanogel@g-Fe2O3 formulations were tested using NG1
or NG2, up to 48 h of incubation with mouse embryo broblast
3T3 cells. A negative control experiment was performed using
cells without any treatment; the inuence of the “empty nano-
gel” (without an iron core) on the cell's viability was also eval-
uated. Each formulation – 2.0 mg mL1 of the nanogel loaded
with 4.0 mM (NG1) or 4.3 mM (NG2) of iron – was diluted in the
culture medium 5 or 10 fold resulting in nanogel concentra-
tions of 0.4 mg mL1 and 0.2 mg mL1, respectively. Bare
g-Fe2O3 nanoparticles could not be tested due to their precipi-
tation in the culture medium.
It is assumed that in the MTT assay the absorbance of MTT
crystals is proportional to the number of viable cells. The
absorbance was determined just before addition of the nanogel
or nanomagnetogel formulations (0 h) and aer incubation for
24 or 48 h. Both NG1 and NG2 samples were tested to ascertain
whether the degree of substitution with hydrophobic chainsJ. Mater. Chem. B, 2013, 1, 5853–5864 | 5861
Fig. 11 Cell proliferation assay, in mouse embryo fibroblast 3T3 cells, after 0, 24 or 48 h of incubation in culture medium (DMEM), with nanogel (NG1 or NG2) or
nanogel@g-Fe2O3 formulations, using different dilution factors (DF). Results represent the mean  S.D. of 3 absorbance values obtained from triplicates of each
condition.
Fig. 12 Uptake of (a) nanogel (NG1) 0.4 mgmL1 or (b) NG1@g-Fe2O3 (nanogel
0.4 mg mL1 and iron 0.8 mM), by murine bone marrow derived macrophages
(BMDM), 3 h after incubation staining with Prussian blue (original magnification
100).
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View Article Onlineaffects cell proliferation. As shown in Fig. 11, cells treated with
either nanogels present similar absorbance to the control
(untreated cells). Therefore, the nanogel has no signicant
effect on cell proliferation, independent of the degree of
substitution or concentrations used. The same conclusion
emerges for nanogel@g-Fe2O3 formulations, indicating that the
presence of iron loaded into the nanogel does not affect the
proliferation of 3T3 broblasts. Therefore, it may be concluded
that the dextrin nanomagnetogel is not cytotoxic.
3.2.3. Phagocytic activity – Prussian blue. The mechanism
of the cellular uptake of nanoparticles and their biodistribution
depend on the physico-chemical properties of the particles and
in particular on their surface characteristics. Moreover, as
particles are mainly recognized and engulfed by immune cells,
special attention should be paid to nano-immuno interactions.
It is also important to use primary cells for testing the
biocompatibility of nanoparticles, as they are closer to the in
vivo situation when compared to transformed cell lines.46
Fig. 12 shows the efficient uptake of the nanomagnetogel by
BMDMs. The cells were stained with Prussian blue to detect the
intracellular iron content. The negative control (Fig. 12a) did
not show any blue staining. When cells are incubated with the
nanomagnetogel (Fig. 12b), the blue colour is clearly visible
within cells, revealing the nanomagnetogel internalization by
macrophages, 3 h aer in vitro incubation. Therefore, it can be5862 | J. Mater. Chem. B, 2013, 1, 5853–5864assumed that the studied formulations are expected to be
internalized by phagocytic cells, namely macrophages, aer in
vivo administration, resulting in spleen and liver accumulation.
In this way, the formulations developed in this study present
great potential as contrast agents for RES rich organs (spleen,
liver). Future work intends to use a PEG-decorated nano-
magnetogel aiming to escape the phagocytic system and target
different organs. Additional molecules can be used for active
targeting on the nanomagnetogel surface.4. Conclusions
In this study, we have shown that the nanomagnetogel
production is simple, reproducible, and exhibits long-term
colloidal stability (in water dispersions), at least up to 8 weeks.
Our rst goal was to explore nanogel loading efficacy, using
different nanogel/g-Fe2O3 ratios and nanogels with different
degrees of substitution with alkyl chains (hydrophobic part).
The inner structure of the nanomagnetogel was elucidated by
combining dynamic light scattering, transmission electron
microscopy and small-angle X-ray scattering analysis.
The nanomagnetogel has a diameter of around 100 nm and
comprises superparamagnetic nanoparticles randomly distrib-
uted within the polymer structure. The surrounding corona of
dextrin allows iron oxide stabilization avoiding aggregation at
physiological pH. The nanogel with the lowest degree of substi-
tution with alkyl chains (NG1) 2.0mgmL1 and 10.0mMof initial
iron concentration was selected as the most interesting formula-
tion, which corresponds to a nanomagnetogel with about 4.0 mM
iron content. Incorporation of iron oxide within the nanogel
structure results in promising relaxometric properties, essentially
as a T2 contrast agent for MRI. Our nanomagnetogel exhibits
superior r2 values to commercially available formulations.
The nanomagnetogel formulations offer the possibility of
magnetic accumulation, through an external magnetic eld, to
a targeted area, without compromising the nanomagnetogel
integrity. The efficient internalization of the nanomagnetogelThis journal is ª The Royal Society of Chemistry 2013
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View Article Onlineby BMDM leads to the inference that, aer intravenous
administration, formulations will certainly be internalized by
phagocytic cells, resulting in the accumulation in RES rich
organs (spleen, liver). The nanogel and nanomagnetogel
demonstrate no cytotoxic effect on 3T3 broblast cultures, up to
48 h of incubation.Acknowledgements
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